Raines S - Search Results

1

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

Mellion ML, Ronco L, Berends CL, Pagan L, Brooks S, van Esdonk MJ, van Brummelen EMJ, Odueyungbo A, Thompson LA, Hage M, Badrising UA, Raines S, Tracewell WG, van Engelen B, Cadavid D, Groeneveld GJ. Mellion ML, et al. Among authors: raines s. Br J Clin Pharmacol. 2021 Dec;87(12):4658-4669. doi: 10.1111/bcp.14884. Epub 2021 May 14. Br J Clin Pharmacol. 2021. PMID: 33931884 Free article. Clinical Trial.

2

SAGE-217, A Novel GABA_A Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.

Hoffmann E, Nomikos GG, Kaul I, Raines S, Wald J, Bullock A, Sankoh AJ, Doherty J, Kanes SJ, Colquhoun H. Hoffmann E, et al. Among authors: raines s. Clin Pharmacokinet. 2020 Jan;59(1):111-120. doi: 10.1007/s40262-019-00801-0. Clin Pharmacokinet. 2020. PMID: 31338688 Free PMC article. Clinical Trial.

3

Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC).

Shaffer R, Thurman AJ, Ronco L, Cadavid D, Raines S, Kim SH. Shaffer R, et al. Among authors: raines s. J Neurodev Disord. 2022 Jan 8;14(1):4. doi: 10.1186/s11689-021-09411-z. J Neurodev Disord. 2022. PMID: 35034602 Free PMC article.

4

Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.

Kanes SJ, Colquhoun H, Doherty J, Raines S, Hoffmann E, Rubinow DR, Meltzer-Brody S. Kanes SJ, et al. Among authors: raines s. Hum Psychopharmacol. 2017 Mar;32(2):e2576. doi: 10.1002/hup.2576. Hum Psychopharmacol. 2017. PMID: 28370307 Free PMC article. Clinical Trial.

5

Brexanolone as adjunctive therapy in super-refractory status epilepticus.

Rosenthal ES, Claassen J, Wainwright MS, Husain AM, Vaitkevicius H, Raines S, Hoffmann E, Colquhoun H, Doherty JJ, Kanes SJ. Rosenthal ES, et al. Among authors: raines s. Ann Neurol. 2017 Sep;82(3):342-352. doi: 10.1002/ana.25008. Epub 2017 Sep 11. Ann Neurol. 2017. PMID: 28779545 Free PMC article. Clinical Trial.

6

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.

Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S. Kanes S, et al. Among authors: raines s. Lancet. 2017 Jul 29;390(10093):480-489. doi: 10.1016/S0140-6736(17)31264-3. Epub 2017 Jun 12. Lancet. 2017. PMID: 28619476 Clinical Trial.

7

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.

Bortnick B, El-Khalili N, Banov M, Adson D, Datto C, Raines S, Earley W, Eriksson H. Bortnick B, et al. Among authors: raines s. J Affect Disord. 2011 Jan;128(1-2):83-94. doi: 10.1016/j.jad.2010.06.031. Epub 2010 Aug 6. J Affect Disord. 2011. PMID: 20691481 Clinical Trial.

8

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.

Litman RE, Smith MA, Doherty JJ, Cross A, Raines S, Gertsik L, Zukin SR. Litman RE, et al. Among authors: raines s. Schizophr Res. 2016 Apr;172(1-3):152-7. doi: 10.1016/j.schres.2016.02.001. Epub 2016 Feb 26. Schizophr Res. 2016. PMID: 26922656 Clinical Trial.

9

Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).

Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S; TEENZ Study Group. Winner P, et al. Among authors: raines s. Headache. 2016 Jul;56(7):1107-19. doi: 10.1111/head.12859. Epub 2016 Jun 22. Headache. 2016. PMID: 27329280 Clinical Trial.

10

Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder with peripartum onset: A multicenter, open-label, controlled proof-of-concept clinical trial (DELOS-1).

Deligiannidis KM, Robakis T, Homitsky SC, Ibroci E, King B, Jacob S, Coppola D, Raines S, Alataris K. Deligiannidis KM, et al. Among authors: raines s. J Affect Disord. 2022 Nov 1;316:34-41. doi: 10.1016/j.jad.2022.07.068. Epub 2022 Aug 4. J Affect Disord. 2022. PMID: 35932937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page